Omnicell Reports Q3 Revenue and Earnings Above Guidance

Reuters

2025/10/30

<a href="https://laohu8.com/S/OMCL">Omnicell</a> Reports Q3 Revenue and Earnings Above Guidance

Omnicell Inc. reported its financial results for the third quarter ended September 30, 2025. The company posted total non-GAAP net income of $24.0 million, or $0.51 per diluted share, compared to $26.0 million, or $0.56 per diluted share, in the third quarter of 2024. Total non-GAAP EBITDA for the third quarter of 2025 was $41.0 million, up from $39.0 million in the same period last year. Cash and cash equivalents as of September 30, 2025, were $180.0 million, with total debt of $167.0 million and total assets of $1.9 billion. Cash flows from operating activities for the third quarter of 2025 were $28.0 million, compared to $23.0 million in the third quarter of 2024. During the third quarter, Omnicell repaid the remaining principal balance of $175.0 million in convertible senior notes that matured. The company highlighted its flagship point-of-care connected devices as the main driver of business during the period. For the full year, Omnicell provided non-GAAP EBITDA guidance of $140.0 million to $146.0 million and non-GAAP earnings per share guidance of $1.63 to $1.73.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omnicell Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251030245772) on October 30, 2025, and is solely responsible for the information contained therein.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2579111929"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2579111929\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2579111929?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-30 18:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2579111929","market":"nz","top_or_hot":-1,"title":"Omnicell Reports Q3 Revenue and Earnings Above Guidance","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> Reports Q3 Revenue and Earnings Above Guidance\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Omnicell Inc. reported its financial results for the third quarter ended September 30, 2025. The company posted total non-GAAP net income of $24.0 million, or $0.51 per diluted share, compared to $26.0 million, or $0.56 per diluted share, in the third quarter of 2024. Total non-GAAP EBITDA for the third quarter of 2025 was $41.0 million, up from $39.0 million in the same period last year. Cash and cash equivalents as of September 30, 2025, were $180.0 million, with total debt of $167.0 million and total assets of $1.9 billion. Cash flows from operating activities for the third quarter of 2025 were $28.0 million, compared to $23.0 million in the third quarter of 2024. During the third quarter, Omnicell repaid the remaining principal balance of $175.0 million in convertible senior notes that matured. The company highlighted its flagship point-of-care connected devices as the main driver of business during the period. For the full year, Omnicell provided non-GAAP EBITDA guidance of $140.0 million to $146.0 million and non-GAAP earnings per share guidance of $1.63 to $1.73.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omnicell Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251030245772) on October 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Omnicell Reports Q3 Revenue and Earnings Above Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOmnicell Reports Q3 Revenue and Earnings Above Guidance\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-10-30 18:30</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/OMCL\">Omnicell</a> Reports Q3 Revenue and Earnings Above Guidance\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Omnicell Inc. reported its financial results for the third quarter ended September 30, 2025. The company posted total non-GAAP net income of $24.0 million, or $0.51 per diluted share, compared to $26.0 million, or $0.56 per diluted share, in the third quarter of 2024. Total non-GAAP EBITDA for the third quarter of 2025 was $41.0 million, up from $39.0 million in the same period last year. Cash and cash equivalents as of September 30, 2025, were $180.0 million, with total debt of $167.0 million and total assets of $1.9 billion. Cash flows from operating activities for the third quarter of 2025 were $28.0 million, compared to $23.0 million in the third quarter of 2024. During the third quarter, Omnicell repaid the remaining principal balance of $175.0 million in convertible senior notes that matured. The company highlighted its flagship point-of-care connected devices as the main driver of business during the period. For the full year, Omnicell provided non-GAAP EBITDA guidance of $140.0 million to $146.0 million and non-GAAP earnings per share guidance of $1.63 to $1.73.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omnicell Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251030245772) on October 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"醫療保健技術","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL7frybw:1","article_id":"2579111929","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2579111929","pubTimestamp":1761820247,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Omnicell Inc. reported its financial results for the third quarter ended September 30, 2025. The company posted total non-GAAP net income of $24.0 million, or $0.51 per diluted share, compared to $26.0 million, or $0.56 per diluted share, in the third quarter of 2024. Total non-GAAP EBITDA for the third quarter of 2025 was $41.0 million, up from $39.0 million in the same period last year. Cash and cash equivalents as of September 30, 2025, were $180.0 million, with total debt of $167.0 million and total assets of $1.9 billion. Cash flows from operating activities for the third quarter of 2025 were $28.0 million, compared to $23.0 million in the third quarter of 2024. During the third quarter, Omnicell repaid the remaining principal balance of $175.0 million in convertible senior notes that matured. The company highlighted its flagship point-of-care connected devices as the main driver of business during the period. For the full year, Omnicell provided non-GAAP EBITDA guidance of $140.0","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","OMCL":"Omnicell","BK4082":"医疗保健设备"},"translate_title":"Omnicell报告第三季度收入和盈利高于预期","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMCL":0.9},"content_text":"Omnicell Reports Q3 Revenue and Earnings Above Guidance\n    \n\n        Omnicell Inc. reported its financial results for the third quarter ended September 30, 2025. The company posted total non-GAAP net income of $24.0 million, or $0.51 per diluted share, compared to $26.0 million, or $0.56 per diluted share, in the third quarter of 2024. Total non-GAAP EBITDA for the third quarter of 2025 was $41.0 million, up from $39.0 million in the same period last year. Cash and cash equivalents as of September 30, 2025, were $180.0 million, with total debt of $167.0 million and total assets of $1.9 billion. Cash flows from operating activities for the third quarter of 2025 were $28.0 million, compared to $23.0 million in the third quarter of 2024. During the third quarter, Omnicell repaid the remaining principal balance of $175.0 million in convertible senior notes that matured. The company highlighted its flagship point-of-care connected devices as the main driver of business during the period. For the full year, Omnicell provided non-GAAP EBITDA guidance of $140.0 million to $146.0 million and non-GAAP earnings per share guidance of $1.63 to $1.73.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Omnicell Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20251030245772) on October 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}